Last update 01 Nov 2024

Cardio Therapeutics Pty Ltd.

Subsidiary Company|
Australia

Overview

Basic Info

Introduction
Cardio Therapeutics Pty Ltd. (NASDAQ: CRDL) (TSX: CRDL)manufactures and sells pharmaceutical products. The company was founded on January 2, 2014 and is headquartered in Blackburn, Australia.Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease.

Tags

Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PCSK9(Proprotein convertase subtilisin kexin type 9)1

Related

1
Drugs associated with Cardio Therapeutics Pty Ltd.
NYX-330
Target
PCSK9
Mechanism
PCSK9 inhibitors
Active Org.
Cardio Therapeutics Pty Ltd.
Originator Org.
Cardio Therapeutics Pty Ltd.
Active Indication
Hypercholesterolemia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Cardio Therapeutics Pty Ltd.
Login to view more data
0 Patents (Medical) associated with Cardio Therapeutics Pty Ltd.
Login to view more data
100 Deals associated with Cardio Therapeutics Pty Ltd.
Login to view more data
100 Translational Medicine associated with Cardio Therapeutics Pty Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NYX-330
 ( PCSK9 )		Hypercholesterolemia
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free